Pharmaceutical Intermediate Raw Material Chemicals Powder Aripiprazole CAS 129722-12-9

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: ST-Aripiprazole
• Certification: ISO 9001, FDA
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Use: Healthy
• MOQ: 10g
• Molecular Formula: C23h27cl2n3o2
• CAS: 129722-12-9
• Einecs: /
• Appearance: Powder
• Colour: White
• Sample: Available
• Delivery: 3-5day
• Spe: Free Sample
• Capacity: 50000kg/Mouth
• Supply Type: OEM/ODM
• Quality: Industrial
• Type: Pharmaceutical Intermediates
• Certificate: ISO 9001
• Transport Package: 1kg/Bag, 25kg/Drum
• Specification: 99%
• Trademark: SENTIAN
• Origin: China
• Production Capacity: 50000 Kg Per Month

Product Description

.

 

Description

 

 

Prodcut name	Aripiprazole
Synonyms	7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro-2(1H)-quinolinone;7-{4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy}-3,4-dihydro-2(1H)-quinolinone;Aripiprazole;7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one;
MOQ	10g
CAS	129722-12-9
Appearance	Powder
Molecular Formula	C23H27Cl2N3O2
Molecular Weight	448.385
Assay	99%
Application	Pharma grade
Packing	As per your request
Storage	Preserve in tight, light-resistant containers in a cool place
Remarks	NA
Custom synthesis	Available

COA

Item	Specification	Test result
Appearance	white powder	Conforms
Assay	99%	Conforms
Heavy metal	≤10ppm	Conforms
Lead	≤2.0ppm	Conforms
As	≤2.0ppm	Conforms
Ca	≤1.0ppm	Conforms
Me	≤0.1ppm	Conforms
Total aerobic microbial count	≤1000CFU/g	Conforms
Total moulds&yeast count	≤100CFU/g	Conforms
Enterobacterial	≤10MPN/g	Conforms
Salmonella	N.D/25g	Conforms
Escherichia coli	N.D/10g	Conforms
Staphylococcus aureus	N.D/10g	Conforms
Pseudomonas aeruginosa	N.D/10g	Conforms
Conclusion: Conform with specification.

 

 

Application & Funtion

1.A deuterated version of Aripiprazole, a selective dopamine D2-receptor antagonist with dopamine autoreceptor agonist activity. Please note that users have reported separation of this compound and aripiprazole under normal-phase and reverse-phase
2.A selective dopamine D2-receptor antagonist with dopamine autoreceptor agonist activity. Antipsychotic.
3.cerebral vasodilator, antimotion
4.For the treatment of schizophrenia and related psychotic disorders.

Company